|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Pitolisant>> Market Analysis Reports |
Market Analysis Reports of Pitolisant |
|
2020 Narcolepsy Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... (sodium oxybate), BTD-001 (Pentylenetetrazole), pitolisant, RO5256390, mazindol, JZP-258, JZP ... Narcolepsy- Market Insight, Epidemiology and Market Forecast - 2028 ... Pharmaceutical Co., Ltd.), THN102 (Theranexus) and pitolisant (Bioprojet Pharma) have been covered ... Narcolepsy Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 ... recent developments: Approval of Pitolisant (Wakix): The approval of pitolisant has marked a significant ... approval of new medications such as pitolisant (Wakix) and the expanded ... include the increased availability of pitolisant and efforts to improve patient ... Narcolepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Narcolepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy - Drugs In Development, 2022, provides an ... Narcolepsy - Pipeline Review, H1 2020 Narcolepsy - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy - Pipeline Review, H1 2020, provides an overview of the Narcolepsy (Central Nervous System) pipeline landscape. ... Fatigue Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Fatigue Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fatigue Drugs in Development by Stages, Target, MoA, RoA, ... Prader-Willi Syndrome (PWS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Prader-Willi Syndrome (PWS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prader-Willi Syndrome (PWS) - Drugs in ... Global Narcolepsy Drugs Market (By Therapeutic Type, Disease Type, End User, Regional Analysis), Pipeline Analysis, Key Company Profiles and Recent Developments - Forecast to 2030 ... the marketing authorization for WAKIX (pitolisant), which is now indicated for the ... Hypersomnia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major hypersomnia markets are expected to exhibit a CAGR of 6.68% during 2024-2034. The hypersomnia market has been comprehensively analyzed in IMARC's new report titled "Hypersomnia Market: Epidemiology, Industry Trends, Share, Size, Growth, ... Myotonic Dystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major myotonic dystrophy markets reached a value of US$ 96.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 260.4 Million by 2034, exhibiting a growth rate (CAGR) of 9.45% during 2024-2034. The myotonic dystrophy market ... |